|
|
|
Volumn 17, Issue 3-4, 1996, Pages 865-870
|
|
Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease
a
|
|
Author keywords
Dev NGF Treatment Peri Neuropathy; Mast Cells; NGF; Peripheral Neuropathy; Preclinical Toxicology
|
|
Indexed keywords
ANTIBODY;
ANTINEOPLASTIC AGENT;
NERVE GROWTH FACTOR;
NERVE GROWTH FACTOR RECEPTOR;
NEUROTROPHIN;
OXYGEN;
ANAPHYLAXIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFECT;
DRUG EFFICACY;
ETIOLOGY;
HUMAN;
HYPERALGESIA;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MAST CELL DEGRANULATION;
MYALGIA;
NEUROTOXICITY;
NONHUMAN;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
ANIMALIA;
|
|
EID: 0030432187
PISSN: 0161813X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (22)
|
|
References (45)
|
